Boulder, CO, United States of America

Bryn Grimison

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2019.


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bryn Grimison: Innovator in Biochemistry

Introduction

Bryn Grimison is a notable inventor based in Boulder, CO (US). She has made significant contributions to the field of biochemistry, particularly in the area of protein refolding. Her innovative work has implications for various applications in biotechnology and pharmaceuticals.

Latest Patents

Bryn holds a patent for a process titled "Process for refolding recombinant chymotrypsin." This invention describes a method for refolding recombinant chymotrypsin produced from prokaryote host cells. The process aims to enhance the efficiency and effectiveness of protein refolding, which is crucial for the production of functional proteins in therapeutic applications. She has 1 patent to her name.

Career Highlights

Bryn Grimison is currently employed at Merck Sharp & Dohme Corp., a leading global healthcare company. Her role involves research and development in biochemistry, where she applies her expertise to advance the company's innovative projects.

Collaborations

Throughout her career, Bryn has collaborated with esteemed colleagues, including Mark C Sleevi and Jack Lile. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Bryn Grimison's contributions to biochemistry through her innovative patent and work at Merck Sharp & Dohme Corp. highlight her role as a significant figure in the field. Her dedication to advancing protein refolding processes showcases the impact of her work on biotechnology and pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…